SlideShare une entreprise Scribd logo
1  sur  19
1
Dosage Regimen
Presented By…
Shah Vrushank N.
2
 Introduction
 Multiple Dosing
 Designing of Dosage regimen
 Concept of Loading Dose.
 Maintenance Dose.
 Accumulation Index.
 References
3
Introduction
 Definition :- Dosage regimen is defined as the Manner in
which a drug is taken.
 For successful therapy, design of an optimal multiple dosage
regimen is necessary.
 Multiple dosage regimen:- is defined as the manner in which
the drug is administered in suitable doses by suitable route,
with sufficient frequency that insures maintenance of plasma
conc. within therapeutic window for entire period of therapy.
 In designing a dosage regimen:-
• All p’kinetic parameters of the drug remain constant during the
course of therapy once the Dosage regimen is established.
• The calculations are based on one- compartment model which
can also applied for two- compartment models. β KE
Vd,ss Vd
4
 In Designing dosage
regimen the two major
parameters that can be
adjusted in developing a
dosage regimen are…
1) The Dose size – The qty.
of Drug administered.
 Greater dose size
greater fluctuation btw
Cssmax, & Cssminand greater
chance of toxicity
2) The Dosing frequency –
The time interval
between Doses.
5
Design of dosage regimen from plasma
concentration :
 If the Vd and clearance or half life of the drug is known,
then dosage regimen can be design to maintain the drug
conc. in the therapeutic range.
 Maximum dosing interval which ideally depends upon the
therapeutic index and elimination half life of the drug can
be expressed as :
 ‫ז‬‫ז‬ max = 2.303 log ( Cupper / Clower )
KE
Where KE = 0.693/t1/2
6
 ‫ז‬‫ז‬ max= 3.32 t1/2 log ( Cupper / Clower )
 Mostly dosing interval selected is always smaller than ‫ז‬‫ז‬ max
 the maximum maintenance dose X0maxcan be expressed as
 X0max= Vd ( Cupper - Clower )
F
After the convenient dosing interval ‫ז‬‫ז‬ ,, smaller thansmaller than ‫ז‬‫ז‬ max has
been selected, maintenance dose is given as :
X0 = Css,av =
Xo max
‫ז‬‫ז‬ maxmax
‫ז‬‫ז‬
( Cupper / Clower )
2.303 log ( Cupper / Clower )
7
Multiple dosing
 For chronic diseases, there is necessity of multiple dosing
i.e. administration of drugs in number of frequencies.
 On continuous steady administration of a drug, plasma
concentration will rise fast at first then more slowly and
reach a plateau, where:
Rate of administration = Rate of elimination
( steady state is achieved )
 Therefore, at steady state:
Dose (Rate of Administration) = Clearance x Plasma conc.
Or
If you aim at a target plasma level and you know the
clearance, you can calculate the dose required.`
8
Effect of multiple doses
 If the plasma concentration prior to next dose is >0
concentration and elimination is of first order, then plasma
concentration will increase Increase in elimination rate
and eventually steady state.
– For first order elimination kinetic the time to obtain
steady state is dependent only of the half time of the drug
– The steady state concentration is determinated by dose
(D) and dose frequency
9
 Effects of dose and dose frequencyEffects of dose and dose frequency
 Increase in doseIncrease in dose
– Increase in CIncrease in Cmeanmean
– Larger difference between CLarger difference between Cmaxmax and Cand Cminmin
– Increased risk for side effects for drugs with smallIncreased risk for side effects for drugs with small
therapeutic windowstherapeutic windows
 Increase in frequencyIncrease in frequency
– Increase in CIncrease in Cmeanmean
– Larger inconvenience for patientLarger inconvenience for patient
10
Loading Dose
 Concept of loading dose
 For drugs with long half-lives, the time to reach steady
state might be long. It takes about 5 half- lives to reach
steady state.
 In a such cases the plateau can be achieved by
administering a dose that gives the desired steady- state.
Such an initial/ first dose is called as Loading dose.
XXo,o,L =L =
CCss,avss,av VVdd
FF
11
 When Vd is not known then loading dose may be
calculated as
 The above eq. is applied when Ka >> Ke & drug is
distributed rapidly.
 But in case of I.V. route the absorption is very fast
therefore , absorption phase is neglected then above eq.
XXooLL
XX00 (1 –e(1 –e –Ka–Ka‫ז‬‫ז‬
)) (1 – e(1 – e –Ke–Ke ‫ז‬‫ז‬
)
11
=
XXo,o,LL
XX00
=
1 – e1 – e -Ke-Ke‫ז‬‫ז‬
11
= R= Racac
12
Maintenance Dose
 After the loading dose is given the another dose (I.V) is
given to maintain the steady- state drug conc. Or plateau.
Such dose is known as maintenance dose.
 i.e. maintain the response of drug by replacing drug lost
during dosing interval.
 Maintenance dose = loading dose x ( 1- e -k‫ז‬
)
 Loading dose =
maintenance dosemaintenance dose
1 – e1 – e -K-K ‫ז‬‫ז‬
13
 The ratio of loading dose
to maintenance dose
(X0L/X0) is called as dose
ratio
 When ‫ז‬ = t1/2 the dose ratio
=2.0
 When ‫ז‬ > t1/2 the dose ratio
< 2.0
 when ‫ז‬ < t1/2 the dose ratio
>2.0
14
Accumulation Index
 In case of multiple dosage regimen (drugs are frequently
administered) in such a cases the 1st
drug conc. remaining
in a body after certain time, is added to the next dose, this
condition is known as ‘Accumulation’
 The accumulation occurs because previous doses has not
been removed completely from body.
 After some time the rate of absorption is equal to rate of
elimination i.e. conc. of drug in plasma approaches to a
constant value this condition is called as steady- state,
plateau/ infusion equilibrium.
15
16
 Consider the Amount of drug in the body-time profile as
shown in the Graph.
 After admin of first dose X0 = 1X0
 At next dosing interval when X = ½ X0, amt of drug
remaining in the body
 Admin of next i.v. dose raises the body content to
X = X0+ 1
/2X0
 As the amount of drug in the body rises gradually due to
Accumulation, the rate of elimination also rises
proportionally until a steady-state or Plateau is reached.
17
 The maximum & minimum values of X i.e. Xss,max & Xss,min
approach respective asymptotes at plateau.
 Plateau Xss,min = 1X0 (amt of drug in body after first dose ) Xss,max =
2X0 ( equals twice the first dose)
 Also (Xss,max- Xss,min) = X0
 Xss,max / Xss,min = 2
 All this applied only when ‫ז‬ = t1/2
18
 When ‫ז‬ < t1/2 , the degree of Accumulation is greater & vice-
versa.
 Thus, the extent to which a drug accumulates in the body
during multiple dosing, is a function of dosing interval &
elimination half life & is independent of dose size.
 The extent to which a drug will accumulate with any dosing
interval in the patient can be derived from information
obtained with a single dose and is given by accumulation
index Rac as:
 =Rac
1
1-e -KE ‫ז‬
19
References
 ‘Applied Biopharmaceutics & Pharmacokinetics’
by Leon Shargel & Andrew B. C. Yu, 4th
Edition
 ‘Biopharmaceutics & Pharmacokinetics’
A Treatise, D. M. Brahmankar & Sunil B. Jaiswal
 ‘Clinical Pharmacokinetics, Concepts &
Application’, 3rd
Edition,
by Malcom Rowland & Thomas N. Tozer, Lea & Febiger
 www.google.com

Contenu connexe

Tendances

WAGNER NELSON METHOD (Contact me: dr.m.bharathkumar@gmail.com)
WAGNER NELSON METHOD (Contact me: dr.m.bharathkumar@gmail.com)WAGNER NELSON METHOD (Contact me: dr.m.bharathkumar@gmail.com)
WAGNER NELSON METHOD (Contact me: dr.m.bharathkumar@gmail.com)DR. METI.BHARATH KUMAR
 
Bioavailability and Bioequivalence Studies
Bioavailability and Bioequivalence StudiesBioavailability and Bioequivalence Studies
Bioavailability and Bioequivalence StudiesDr. Kunal Chitnis
 
one compartment model ppt
one compartment model pptone compartment model ppt
one compartment model pptSheetal Jha
 
ONE COMPARTMENT OPEN MODEL I.V BOLUS (Contact me: dr.m.bharathkumar@gmail.com)
ONE COMPARTMENT OPEN MODEL I.V BOLUS (Contact me: dr.m.bharathkumar@gmail.com)ONE COMPARTMENT OPEN MODEL I.V BOLUS (Contact me: dr.m.bharathkumar@gmail.com)
ONE COMPARTMENT OPEN MODEL I.V BOLUS (Contact me: dr.m.bharathkumar@gmail.com)DR. METI.BHARATH KUMAR
 
Drug distribution
Drug distributionDrug distribution
Drug distributionNaser Tadvi
 
Compartment Modelling
Compartment ModellingCompartment Modelling
Compartment ModellingPallavi Kurra
 
Pharmacokinetics / Biopharmaceutics - One compartment model IV bolus
Pharmacokinetics / Biopharmaceutics - One compartment model IV bolusPharmacokinetics / Biopharmaceutics - One compartment model IV bolus
Pharmacokinetics / Biopharmaceutics - One compartment model IV bolusAreej Abu Hanieh
 
Methods to determine area under curve
Methods to determine area under curveMethods to determine area under curve
Methods to determine area under curveMd.Rakibul Islam
 
Two compartment model
Two compartment modelTwo compartment model
Two compartment modelRooma Khalid
 
Non linear Pharmacokinetics
Non linear PharmacokineticsNon linear Pharmacokinetics
Non linear PharmacokineticsAreej Abu Hanieh
 
Biopharmaceutics: Mechanisms of Drug Absorption
Biopharmaceutics: Mechanisms of Drug AbsorptionBiopharmaceutics: Mechanisms of Drug Absorption
Biopharmaceutics: Mechanisms of Drug AbsorptionSURYAKANTVERMA2
 
Bioavailability and bioequivalence
Bioavailability and bioequivalenceBioavailability and bioequivalence
Bioavailability and bioequivalenceNaresh Gorantla
 
METHOD OF RESIDUALS
METHOD OF RESIDUALSMETHOD OF RESIDUALS
METHOD OF RESIDUALSDivya Pushp
 
Protein drug binding
Protein drug bindingProtein drug binding
Protein drug bindingSagar Savale
 
Causes of Non linear pharmacokinetics
Causes of Non linear pharmacokineticsCauses of Non linear pharmacokinetics
Causes of Non linear pharmacokineticsSnehal Patel
 
clinical pharmacy
clinical pharmacyclinical pharmacy
clinical pharmacySohan Patel
 

Tendances (20)

Non compartment model
Non compartment modelNon compartment model
Non compartment model
 
WAGNER NELSON METHOD (Contact me: dr.m.bharathkumar@gmail.com)
WAGNER NELSON METHOD (Contact me: dr.m.bharathkumar@gmail.com)WAGNER NELSON METHOD (Contact me: dr.m.bharathkumar@gmail.com)
WAGNER NELSON METHOD (Contact me: dr.m.bharathkumar@gmail.com)
 
Bioavailability and Bioequivalence Studies
Bioavailability and Bioequivalence StudiesBioavailability and Bioequivalence Studies
Bioavailability and Bioequivalence Studies
 
one compartment model ppt
one compartment model pptone compartment model ppt
one compartment model ppt
 
Bioavailability testing protocol
Bioavailability testing protocolBioavailability testing protocol
Bioavailability testing protocol
 
ONE COMPARTMENT OPEN MODEL I.V BOLUS (Contact me: dr.m.bharathkumar@gmail.com)
ONE COMPARTMENT OPEN MODEL I.V BOLUS (Contact me: dr.m.bharathkumar@gmail.com)ONE COMPARTMENT OPEN MODEL I.V BOLUS (Contact me: dr.m.bharathkumar@gmail.com)
ONE COMPARTMENT OPEN MODEL I.V BOLUS (Contact me: dr.m.bharathkumar@gmail.com)
 
Drug distribution
Drug distributionDrug distribution
Drug distribution
 
Compartment Modelling
Compartment ModellingCompartment Modelling
Compartment Modelling
 
Pharmacokinetics / Biopharmaceutics - One compartment model IV bolus
Pharmacokinetics / Biopharmaceutics - One compartment model IV bolusPharmacokinetics / Biopharmaceutics - One compartment model IV bolus
Pharmacokinetics / Biopharmaceutics - One compartment model IV bolus
 
Pharmacokinetic models
Pharmacokinetic modelsPharmacokinetic models
Pharmacokinetic models
 
Methods to determine area under curve
Methods to determine area under curveMethods to determine area under curve
Methods to determine area under curve
 
Two compartment model
Two compartment modelTwo compartment model
Two compartment model
 
Non linear Pharmacokinetics
Non linear PharmacokineticsNon linear Pharmacokinetics
Non linear Pharmacokinetics
 
Excretion of drug
Excretion of drugExcretion of drug
Excretion of drug
 
Biopharmaceutics: Mechanisms of Drug Absorption
Biopharmaceutics: Mechanisms of Drug AbsorptionBiopharmaceutics: Mechanisms of Drug Absorption
Biopharmaceutics: Mechanisms of Drug Absorption
 
Bioavailability and bioequivalence
Bioavailability and bioequivalenceBioavailability and bioequivalence
Bioavailability and bioequivalence
 
METHOD OF RESIDUALS
METHOD OF RESIDUALSMETHOD OF RESIDUALS
METHOD OF RESIDUALS
 
Protein drug binding
Protein drug bindingProtein drug binding
Protein drug binding
 
Causes of Non linear pharmacokinetics
Causes of Non linear pharmacokineticsCauses of Non linear pharmacokinetics
Causes of Non linear pharmacokinetics
 
clinical pharmacy
clinical pharmacyclinical pharmacy
clinical pharmacy
 

En vedette

pharmacokinetic of iv infusion
pharmacokinetic of iv infusionpharmacokinetic of iv infusion
pharmacokinetic of iv infusionDr.saqib habib
 
Area under the curve- Dr ASHWIN R
Area under the curve- Dr ASHWIN RArea under the curve- Dr ASHWIN R
Area under the curve- Dr ASHWIN Rashwin ravi
 
Applications of pharmacokinetics in new drug development,dosage form design &...
Applications of pharmacokinetics in new drug development,dosage form design &...Applications of pharmacokinetics in new drug development,dosage form design &...
Applications of pharmacokinetics in new drug development,dosage form design &...Malla Reddy College of Pharmacy
 
methods of determining drug absorption ppt
methods of determining drug absorption pptmethods of determining drug absorption ppt
methods of determining drug absorption ppttenzin jangchuk
 

En vedette (6)

IV Infusion
IV InfusionIV Infusion
IV Infusion
 
pharmacokinetic of iv infusion
pharmacokinetic of iv infusionpharmacokinetic of iv infusion
pharmacokinetic of iv infusion
 
Area under the curve- Dr ASHWIN R
Area under the curve- Dr ASHWIN RArea under the curve- Dr ASHWIN R
Area under the curve- Dr ASHWIN R
 
Applications of pharmacokinetics in new drug development,dosage form design &...
Applications of pharmacokinetics in new drug development,dosage form design &...Applications of pharmacokinetics in new drug development,dosage form design &...
Applications of pharmacokinetics in new drug development,dosage form design &...
 
methods of determining drug absorption ppt
methods of determining drug absorption pptmethods of determining drug absorption ppt
methods of determining drug absorption ppt
 
Biopharmaceutics
BiopharmaceuticsBiopharmaceutics
Biopharmaceutics
 

Similaire à Dosage regimen

Multiple Dosage Oral Administration/ Dosage Regimen
Multiple Dosage Oral Administration/ Dosage Regimen Multiple Dosage Oral Administration/ Dosage Regimen
Multiple Dosage Oral Administration/ Dosage Regimen Nausheen Fatima
 
APPLICATIONS OF PHARMACOKINETICS Piyush lodhi b. pharma 6th sem
APPLICATIONS OF  PHARMACOKINETICS Piyush lodhi b. pharma 6th sem APPLICATIONS OF  PHARMACOKINETICS Piyush lodhi b. pharma 6th sem
APPLICATIONS OF PHARMACOKINETICS Piyush lodhi b. pharma 6th sem Drx Piyush Lodhi
 
Biopharmaceutics: Multiple dosage regimens
Biopharmaceutics: Multiple dosage regimensBiopharmaceutics: Multiple dosage regimens
Biopharmaceutics: Multiple dosage regimensSonia Barua
 
Application of pharmacokinetics
Application of pharmacokineticsApplication of pharmacokinetics
Application of pharmacokineticsChristy George
 
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciencesTherapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical scienceskhalafpharm
 
sustained release oral dosage forms
sustained release oral dosage formssustained release oral dosage forms
sustained release oral dosage formskajal pradhan
 
Therapeutic Drugs Monitoring
Therapeutic Drugs Monitoring Therapeutic Drugs Monitoring
Therapeutic Drugs Monitoring wadalshigil84
 
6-Plasma Half Life and factor affecting.pptx
6-Plasma Half Life and factor affecting.pptx6-Plasma Half Life and factor affecting.pptx
6-Plasma Half Life and factor affecting.pptxbilaliqbal02
 
Determination of dose and dosing interval
Determination of dose and dosing intervalDetermination of dose and dosing interval
Determination of dose and dosing intervalDr. Ramesh Bhandari
 
One compartment model IV Infusion
One compartment model IV InfusionOne compartment model IV Infusion
One compartment model IV InfusionLakshmiChandran20
 
Determination of dose and dosing interval
Determination of dose and dosing intervalDetermination of dose and dosing interval
Determination of dose and dosing intervalDr. Ramesh Bhandari
 
01Introduction SRDDS AND CRDDS.pptx
01Introduction SRDDS AND CRDDS.pptx01Introduction SRDDS AND CRDDS.pptx
01Introduction SRDDS AND CRDDS.pptxPadmineePatil
 
pharmacokinetics .Pharm.D(one compartment).pptx
pharmacokinetics .Pharm.D(one compartment).pptxpharmacokinetics .Pharm.D(one compartment).pptx
pharmacokinetics .Pharm.D(one compartment).pptxrameshjanga11
 
one compartment open model
one compartment open modelone compartment open model
one compartment open modelSUJITHA MARY
 

Similaire à Dosage regimen (20)

Multiple Dosage Oral Administration/ Dosage Regimen
Multiple Dosage Oral Administration/ Dosage Regimen Multiple Dosage Oral Administration/ Dosage Regimen
Multiple Dosage Oral Administration/ Dosage Regimen
 
Kinetics of multiple dosing
Kinetics of multiple dosingKinetics of multiple dosing
Kinetics of multiple dosing
 
APPLICATIONS OF PHARMACOKINETICS Piyush lodhi b. pharma 6th sem
APPLICATIONS OF  PHARMACOKINETICS Piyush lodhi b. pharma 6th sem APPLICATIONS OF  PHARMACOKINETICS Piyush lodhi b. pharma 6th sem
APPLICATIONS OF PHARMACOKINETICS Piyush lodhi b. pharma 6th sem
 
multiple-dosage-regimen.pdf
multiple-dosage-regimen.pdfmultiple-dosage-regimen.pdf
multiple-dosage-regimen.pdf
 
Biopharmaceutics: Multiple dosage regimens
Biopharmaceutics: Multiple dosage regimensBiopharmaceutics: Multiple dosage regimens
Biopharmaceutics: Multiple dosage regimens
 
Application of pharmacokinetics
Application of pharmacokineticsApplication of pharmacokinetics
Application of pharmacokinetics
 
Pharmacokinetic
PharmacokineticPharmacokinetic
Pharmacokinetic
 
dosage regimen.pptx
dosage regimen.pptxdosage regimen.pptx
dosage regimen.pptx
 
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciencesTherapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
 
sustained release oral dosage forms
sustained release oral dosage formssustained release oral dosage forms
sustained release oral dosage forms
 
Therapeutic Drugs Monitoring
Therapeutic Drugs Monitoring Therapeutic Drugs Monitoring
Therapeutic Drugs Monitoring
 
6-Plasma Half Life and factor affecting.pptx
6-Plasma Half Life and factor affecting.pptx6-Plasma Half Life and factor affecting.pptx
6-Plasma Half Life and factor affecting.pptx
 
Determination of dose and dosing interval
Determination of dose and dosing intervalDetermination of dose and dosing interval
Determination of dose and dosing interval
 
One compartment model IV Infusion
One compartment model IV InfusionOne compartment model IV Infusion
One compartment model IV Infusion
 
Determination of dose and dosing interval
Determination of dose and dosing intervalDetermination of dose and dosing interval
Determination of dose and dosing interval
 
01Introduction SRDDS AND CRDDS.pptx
01Introduction SRDDS AND CRDDS.pptx01Introduction SRDDS AND CRDDS.pptx
01Introduction SRDDS AND CRDDS.pptx
 
pharmacokinetics .Pharm.D(one compartment).pptx
pharmacokinetics .Pharm.D(one compartment).pptxpharmacokinetics .Pharm.D(one compartment).pptx
pharmacokinetics .Pharm.D(one compartment).pptx
 
2.pharmacokinetics
2.pharmacokinetics2.pharmacokinetics
2.pharmacokinetics
 
Dosage Regimen
Dosage RegimenDosage Regimen
Dosage Regimen
 
one compartment open model
one compartment open modelone compartment open model
one compartment open model
 

Dernier

Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsTechSoup
 
JAPAN: ORGANISATION OF PMDA, PHARMACEUTICAL LAWS & REGULATIONS, TYPES OF REGI...
JAPAN: ORGANISATION OF PMDA, PHARMACEUTICAL LAWS & REGULATIONS, TYPES OF REGI...JAPAN: ORGANISATION OF PMDA, PHARMACEUTICAL LAWS & REGULATIONS, TYPES OF REGI...
JAPAN: ORGANISATION OF PMDA, PHARMACEUTICAL LAWS & REGULATIONS, TYPES OF REGI...anjaliyadav012327
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...fonyou31
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactPECB
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Sapana Sha
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)eniolaolutunde
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104misteraugie
 
Disha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdfDisha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdfchloefrazer622
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfsanyamsingh5019
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingTechSoup
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Celine George
 
Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpinRaunakKeshri1
 
Russian Call Girls in Andheri Airport Mumbai WhatsApp 9167673311 💞 Full Nigh...
Russian Call Girls in Andheri Airport Mumbai WhatsApp  9167673311 💞 Full Nigh...Russian Call Girls in Andheri Airport Mumbai WhatsApp  9167673311 💞 Full Nigh...
Russian Call Girls in Andheri Airport Mumbai WhatsApp 9167673311 💞 Full Nigh...Pooja Nehwal
 
social pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajansocial pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajanpragatimahajan3
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptxVS Mahajan Coaching Centre
 
Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Disha Kariya
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeThiyagu K
 

Dernier (20)

Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
JAPAN: ORGANISATION OF PMDA, PHARMACEUTICAL LAWS & REGULATIONS, TYPES OF REGI...
JAPAN: ORGANISATION OF PMDA, PHARMACEUTICAL LAWS & REGULATIONS, TYPES OF REGI...JAPAN: ORGANISATION OF PMDA, PHARMACEUTICAL LAWS & REGULATIONS, TYPES OF REGI...
JAPAN: ORGANISATION OF PMDA, PHARMACEUTICAL LAWS & REGULATIONS, TYPES OF REGI...
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
Disha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdfDisha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdf
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdf
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpin
 
Russian Call Girls in Andheri Airport Mumbai WhatsApp 9167673311 💞 Full Nigh...
Russian Call Girls in Andheri Airport Mumbai WhatsApp  9167673311 💞 Full Nigh...Russian Call Girls in Andheri Airport Mumbai WhatsApp  9167673311 💞 Full Nigh...
Russian Call Girls in Andheri Airport Mumbai WhatsApp 9167673311 💞 Full Nigh...
 
social pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajansocial pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajan
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
 
Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 

Dosage regimen

  • 2. 2  Introduction  Multiple Dosing  Designing of Dosage regimen  Concept of Loading Dose.  Maintenance Dose.  Accumulation Index.  References
  • 3. 3 Introduction  Definition :- Dosage regimen is defined as the Manner in which a drug is taken.  For successful therapy, design of an optimal multiple dosage regimen is necessary.  Multiple dosage regimen:- is defined as the manner in which the drug is administered in suitable doses by suitable route, with sufficient frequency that insures maintenance of plasma conc. within therapeutic window for entire period of therapy.  In designing a dosage regimen:- • All p’kinetic parameters of the drug remain constant during the course of therapy once the Dosage regimen is established. • The calculations are based on one- compartment model which can also applied for two- compartment models. β KE Vd,ss Vd
  • 4. 4  In Designing dosage regimen the two major parameters that can be adjusted in developing a dosage regimen are… 1) The Dose size – The qty. of Drug administered.  Greater dose size greater fluctuation btw Cssmax, & Cssminand greater chance of toxicity 2) The Dosing frequency – The time interval between Doses.
  • 5. 5 Design of dosage regimen from plasma concentration :  If the Vd and clearance or half life of the drug is known, then dosage regimen can be design to maintain the drug conc. in the therapeutic range.  Maximum dosing interval which ideally depends upon the therapeutic index and elimination half life of the drug can be expressed as :  ‫ז‬‫ז‬ max = 2.303 log ( Cupper / Clower ) KE Where KE = 0.693/t1/2
  • 6. 6  ‫ז‬‫ז‬ max= 3.32 t1/2 log ( Cupper / Clower )  Mostly dosing interval selected is always smaller than ‫ז‬‫ז‬ max  the maximum maintenance dose X0maxcan be expressed as  X0max= Vd ( Cupper - Clower ) F After the convenient dosing interval ‫ז‬‫ז‬ ,, smaller thansmaller than ‫ז‬‫ז‬ max has been selected, maintenance dose is given as : X0 = Css,av = Xo max ‫ז‬‫ז‬ maxmax ‫ז‬‫ז‬ ( Cupper / Clower ) 2.303 log ( Cupper / Clower )
  • 7. 7 Multiple dosing  For chronic diseases, there is necessity of multiple dosing i.e. administration of drugs in number of frequencies.  On continuous steady administration of a drug, plasma concentration will rise fast at first then more slowly and reach a plateau, where: Rate of administration = Rate of elimination ( steady state is achieved )  Therefore, at steady state: Dose (Rate of Administration) = Clearance x Plasma conc. Or If you aim at a target plasma level and you know the clearance, you can calculate the dose required.`
  • 8. 8 Effect of multiple doses  If the plasma concentration prior to next dose is >0 concentration and elimination is of first order, then plasma concentration will increase Increase in elimination rate and eventually steady state. – For first order elimination kinetic the time to obtain steady state is dependent only of the half time of the drug – The steady state concentration is determinated by dose (D) and dose frequency
  • 9. 9  Effects of dose and dose frequencyEffects of dose and dose frequency  Increase in doseIncrease in dose – Increase in CIncrease in Cmeanmean – Larger difference between CLarger difference between Cmaxmax and Cand Cminmin – Increased risk for side effects for drugs with smallIncreased risk for side effects for drugs with small therapeutic windowstherapeutic windows  Increase in frequencyIncrease in frequency – Increase in CIncrease in Cmeanmean – Larger inconvenience for patientLarger inconvenience for patient
  • 10. 10 Loading Dose  Concept of loading dose  For drugs with long half-lives, the time to reach steady state might be long. It takes about 5 half- lives to reach steady state.  In a such cases the plateau can be achieved by administering a dose that gives the desired steady- state. Such an initial/ first dose is called as Loading dose. XXo,o,L =L = CCss,avss,av VVdd FF
  • 11. 11  When Vd is not known then loading dose may be calculated as  The above eq. is applied when Ka >> Ke & drug is distributed rapidly.  But in case of I.V. route the absorption is very fast therefore , absorption phase is neglected then above eq. XXooLL XX00 (1 –e(1 –e –Ka–Ka‫ז‬‫ז‬ )) (1 – e(1 – e –Ke–Ke ‫ז‬‫ז‬ ) 11 = XXo,o,LL XX00 = 1 – e1 – e -Ke-Ke‫ז‬‫ז‬ 11 = R= Racac
  • 12. 12 Maintenance Dose  After the loading dose is given the another dose (I.V) is given to maintain the steady- state drug conc. Or plateau. Such dose is known as maintenance dose.  i.e. maintain the response of drug by replacing drug lost during dosing interval.  Maintenance dose = loading dose x ( 1- e -k‫ז‬ )  Loading dose = maintenance dosemaintenance dose 1 – e1 – e -K-K ‫ז‬‫ז‬
  • 13. 13  The ratio of loading dose to maintenance dose (X0L/X0) is called as dose ratio  When ‫ז‬ = t1/2 the dose ratio =2.0  When ‫ז‬ > t1/2 the dose ratio < 2.0  when ‫ז‬ < t1/2 the dose ratio >2.0
  • 14. 14 Accumulation Index  In case of multiple dosage regimen (drugs are frequently administered) in such a cases the 1st drug conc. remaining in a body after certain time, is added to the next dose, this condition is known as ‘Accumulation’  The accumulation occurs because previous doses has not been removed completely from body.  After some time the rate of absorption is equal to rate of elimination i.e. conc. of drug in plasma approaches to a constant value this condition is called as steady- state, plateau/ infusion equilibrium.
  • 15. 15
  • 16. 16  Consider the Amount of drug in the body-time profile as shown in the Graph.  After admin of first dose X0 = 1X0  At next dosing interval when X = ½ X0, amt of drug remaining in the body  Admin of next i.v. dose raises the body content to X = X0+ 1 /2X0  As the amount of drug in the body rises gradually due to Accumulation, the rate of elimination also rises proportionally until a steady-state or Plateau is reached.
  • 17. 17  The maximum & minimum values of X i.e. Xss,max & Xss,min approach respective asymptotes at plateau.  Plateau Xss,min = 1X0 (amt of drug in body after first dose ) Xss,max = 2X0 ( equals twice the first dose)  Also (Xss,max- Xss,min) = X0  Xss,max / Xss,min = 2  All this applied only when ‫ז‬ = t1/2
  • 18. 18  When ‫ז‬ < t1/2 , the degree of Accumulation is greater & vice- versa.  Thus, the extent to which a drug accumulates in the body during multiple dosing, is a function of dosing interval & elimination half life & is independent of dose size.  The extent to which a drug will accumulate with any dosing interval in the patient can be derived from information obtained with a single dose and is given by accumulation index Rac as:  =Rac 1 1-e -KE ‫ז‬
  • 19. 19 References  ‘Applied Biopharmaceutics & Pharmacokinetics’ by Leon Shargel & Andrew B. C. Yu, 4th Edition  ‘Biopharmaceutics & Pharmacokinetics’ A Treatise, D. M. Brahmankar & Sunil B. Jaiswal  ‘Clinical Pharmacokinetics, Concepts & Application’, 3rd Edition, by Malcom Rowland & Thomas N. Tozer, Lea & Febiger  www.google.com